Company intelligence / Profile preview

Injex Pharma

Berlin, Berlin, Germany

Ownership: Private
Employees: ~10
Development stage: Other

Overview

INJEX Pharma is commercializing a CE- and FDA-cleared, needle-free injector for subcutaneous and intradermal delivery (notably for insulin and anesthetic administration). It is marketed globally and has a legacy of clinical use supporting patient-friendly, pain-free delivery for diabetes and other indications.[1][2][3]

Therapeutic areas: PsychiatryEndocrinologyOther
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Medical device distributors worldwide[1]

Beyond the preview

Go deeper on Injex Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Injex Pharma.

Explore the full profile